Cost of transfusion-dependent myelodysplastic syndromes (MDS) in Germany

被引：0
|
作者：
Kuehne, F.
Mittendorf, T.
Voelkl, M.
Lipp, R.
Germing, U.
Vioni-Niemeyer, A.
von der Schulenburg, J. M.
机构：
[1] Leibniz Univ Hannover, Ctr Hlth Econ, Hannover, Germany
[2] Celgene GmbH, Munich, Germany
[3] Innovat Oncol Res & Consulting GmbH, Hamburg, Germany
[4] Univ Dusseldorf, Ctr Haematol & Oncol, Dept Hematol Oncol & Clin Immunol, D-4000 Dusseldorf, Germany
来源：
LEUKEMIA RESEARCH | 2007年 / 31卷
关键词：
D O I：
10.1016/S0145-2126(07)70201-1
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S111 / S111
页数：1
相关论文
共 50 条
  • [41] Transfusion-Dependent Low Risk Myelodysplastic Syndrome (TD LR-MDS): Predictors Of cardiovascular Events and Death
    Fernandez de Gatta, Marta Alonso
    Martin Garcia, Ana
    Lopez Cadenas, Felix
    Pelaez Elena, Diaz
    Jimenez, Tamara
    Maria Hernandez-Rivas, Jesus
    Vallejo Garcia, Victor
    Barreiro Perez, Manuel
    Rodriguez Estevez, Lucia
    Castro Garay, Juan Carlos
    Avila, Diego
    Cabanillas Cabral, Adolfo Alejandro
    Sanchez Pablo, Clara
    Diez-Campelo, Maria
    Sanchez Fernandez, Pedro Luis
    BLOOD, 2019, 134
  • [42] Iron Chelation in Transfusion-Dependent Patients With Low- to Intermediate-1-Risk Myelodysplastic Syndromes
    Lucijanic, Marko
    Lovrinov, Miran
    Skelin, Marko
    ANNALS OF INTERNAL MEDICINE, 2020, 173 (07) : 595 - 595
  • [43] Cost analysis of long-term blood product transfusion support for patients with myelodysplastic syndromes (MDS).
    Gupta, P
    LeRoy, SC
    Bateman, A
    Morrison, VA
    BLOOD, 1998, 92 (10) : 421A - 421A
  • [44] Thalidomide (THAL) significantly improves anemia in selected transfusion-dependent patients with myelodysplastic syndromes (MDS): Relationship to serum and marrow levels of angiogenetic growth factors (AGF).
    Musto, P
    Falcone, A
    Bodenizza, C
    Sanpaolo, G
    Matera, R
    Bisceglia, M
    Carella, AM
    BLOOD, 2001, 98 (11) : 622A - 622A
  • [45] Myelodysplastic syndromes (MDS)
    Reinhard Stauder
    memo - Magazine of European Medical Oncology, 2009, 2 (2) : 108 - 109
  • [46] Myelodysplastic syndromes (MDS)
    Stauder, R.
    MEMO-MAGAZINE OF EUROPEAN MEDICAL ONCOLOGY, 2009, 2 (02) : 108 - 109
  • [47] Myelodysplastic syndromes (MDS)
    Germing, U.
    Kuendgen, A.
    Haas, R.
    Gattermann, N.
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2012, 137 (05) : 183 - 185
  • [48] Myelodysplastic syndromes (MDS)
    Burgstaller S.
    memo - Magazine of European Medical Oncology, 2014, 7 (3) : 134 - 137
  • [49] Patients with myelodysplastic syndromes (MDS) challenge transfusion resources now and in the future
    Plesnila-Frank, C.
    Berger, K.
    Vioni-Niemeyer, A.
    Schramm, W.
    LEUKEMIA RESEARCH, 2007, 31 : S112 - S112
  • [50] Patients with myelodysplastic syndromes (MDS) challenge transfusion resources now and in the future
    Plesnila-Frank, C.
    Rottenkolber, D.
    Berger, K.
    VALUE IN HEALTH, 2007, 10 (06) : A283 - A284
12345